acamprosate calcium (Cadila Healthcare Limited)


Welcome to the PulseAid listing for the acamprosate calcium drug offered from Cadila Healthcare Limited. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cadila Healthcare Limited
NON-PROPRIETARY NAME: acamprosate calcium
SUBSTANCE NAME: ACAMPROSATE CALCIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, DELAYED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-06-01
END MARKETING DATE: 0000-00-00


acamprosate calcium HUMAN PRESCRIPTION DRUG Details:

Item Descriptionacamprosate calcium from Cadila Healthcare Limited
LABELER NAME: Cadila Healthcare Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 333(mg/1)
START MARKETING DATE: 2017-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70771-1057_7e5f02ce-f964-4059-ae7e-a862e17bfe9e
PRODUCT NDC: 70771-1057
APPLICATION NUMBER: ANDA205995

Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingAcamprosate Calcium
Avera McKennan HospitalAcamprosate Calcium
AvKARE, Inc.Acamprosate Calcium
Cadila Healthcare Limitedacamprosate calcium
Carilion Materials ManagementCampral
Glenmark Pharmaceuticals Inc., USAAcamprosate Calcium
Marlex Pharmaceuticals IncAcamprosate Calcium
Mylan Institutional Inc.Acamprosate Calcium
Mylan Pharmaceuticals Inc.Acamprosate Calcium
Teva Pharmaceuticals USA, Inc.Acamprosate Calcium
Zydus Pharmaceuticals (USA) Inc.acamprosate calcium